The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Gilead Sciences
Associations of TACSTD2/TROP2 and NECTIN-4/NECTIN-4 with molecular subtypes, PD-L1 expression and FGFR3 mutational status in two advanced urothelial bladder cancer cohorts.
 
Veronika Bahlinger
Research Funding - Gilead Sciences (Inst)
 
Annalena Branz
No Relationships to Disclose
 
Pamela Strissel
No Relationships to Disclose
 
Reiner Strick
No Relationships to Disclose
 
Fabienne Lange
No Relationships to Disclose
 
Carol-Immanuel Geppert
Honoraria - Sysmex
Travel, Accommodations, Expenses - Sysmex
 
Niklas Klümper
No Relationships to Disclose
 
Michael Hölzel
No Relationships to Disclose
 
Sven Wach
No Relationships to Disclose
 
Helge Taubert
No Relationships to Disclose
 
Danijel Sikic
No Relationships to Disclose
 
Bernd Wullich
No Relationships to Disclose
 
Miriam Angeloni
No Relationships to Disclose
 
Fulvia Ferrazzi
No Relationships to Disclose
 
Lauri Diehl
Employment - Gilead Sciences
 
Maria Kovalenko
No Relationships to Disclose
 
Emon Elboudwarej
Employment - Gilead Sciences
 
Juliane Margarete Juergensmeier
Employment - Gilead Sciences
Stock and Other Ownership Interests - Gilead Sciences
Travel, Accommodations, Expenses - Gilead Sciences
 
Arndt Hartmann
Honoraria - Abbvie; AstraZeneca; BMS; Boehringer Ingelheim; Ipsen; Janssen-Cilag; MSD; Roche
Consulting or Advisory Role - 3DHISTECH; AstraZeneca; Bristol-Myers Squibb; Cepheid; Diaceutics; Illumina; Ipsen; Janssen-Cilag; MSD; NanoString Technologies; Qiagen; Roche
Research Funding - AstraZeneca; BioNTech; Cepheid; Janssen-Cilag; NanoString Technologies; Roche
Expert Testimony - NanoString Technologies
 
Markus Eckstein
Employment - Diaceutics
Honoraria - Astellas Pharma; AstraZeneca; Genomic Health; Janssen-Cilag; Roche
Consulting or Advisory Role - AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; AstraZeneca; Diaceutics; MSD; Roche
Research Funding - Gilead Sciences; STRATIFYER Molecular Pathology
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Diaceutics; Genomic Health; Janssen-Cilag; MSD; Roche